ACAD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

ACADIA Pharmaceuticals (ACAD) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ACAD is expected to report earnings to rise 15.40% to 23 cents per share on March 03

ACADIA Pharmaceuticals ACAD Stock Earnings Reports

Q4'24

Est.

$0.23

Q3'24

Beat

by $0.06

Q2'24

Beat

by $0.02

Q1'24

Beat

by $0.05

Q4'23

Missed

by $0.01

The last earnings report on November 06 showed earnings per share of 20 cents, beating the estimate of 14 cents. With 4.94M shares outstanding, the current market capitalization sits at 2.81B.

View a ticker or compare two or three

Compare

ACAD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ACAD
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ACAD (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of pharmaceuticals drugs for treatment of central nervous system disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

12830 El Camino Real

Phone

+1 858 558-2871

Employees

598

Web

https://www.acadia.com